Asthma does increase the risk of developing obstructive sleep apnea, and the connection is stronger than most people realize. A large meta-analysis published in Scientific Reports found that roughly 50% of adults with asthma have obstructive sleep apnea, compared to an estimated 9% to 38% in the general population. The relationship runs both directions: asthma promotes the airway changes that lead to sleep apnea, and sleep apnea makes asthma harder to control.
How Asthma Raises Sleep Apnea Risk
Sleep apnea happens when the upper airway repeatedly collapses during sleep, cutting off breathing for seconds at a time. Asthma contributes to this collapse through several overlapping mechanisms.
Chronic inflammation is the most direct link. Asthma doesn’t just inflame the lungs. It affects the entire respiratory tract, from the nasal passages down to the smallest airways. That inflammation causes swelling in the throat tissues, thickening of the airway walls, and structural changes that narrow the space air has to pass through. Over time, this remodeling makes the upper airway more prone to collapsing when the muscles relax during sleep.
Nasal congestion plays a major role too. Most people with asthma also have chronic rhinitis or sinusitis, which blocks the nasal passages. When your nose is congested, breathing shifts to the mouth, which changes the pressure dynamics in the throat. The negative pressure created by trying to pull air through a partially blocked airway can cause the soft tissue to cave inward. Studies show that nasal obstruction rates climb in lockstep with sleep apnea risk: 4.1% of people in the lowest risk group reported chronic nasal blockage, compared to 7.3% in the highest risk group.
Asthma severity matters significantly. Among people with well-controlled asthma, only about 5.6% also had sleep apnea. That number jumped to 61% in those with partially controlled asthma and 33% in those with uncontrolled asthma. The worse the asthma, the more inflammation and structural damage accumulate in the airways, and the higher the odds of developing sleep apnea.
Inhaled Corticosteroids and Sleep Apnea
One of the more surprising findings in recent years is that the medications used to treat asthma may independently raise the risk of sleep apnea. Inhaled corticosteroids, the cornerstone of asthma management, appear to affect the upper airway in ways that promote collapse during sleep.
The risk follows a dose-dependent pattern. People on low-dose inhaled corticosteroids have roughly 2.3 times the odds of developing sleep apnea compared to those not using them. At medium doses, that rises to about 3.7 times. At high doses, it reaches 5.4 times. One study of 284 asthma patients found a fourfold increase in sleep apnea risk associated with inhaled corticosteroid use, regardless of how severe the underlying asthma was.
The mechanism appears to be local rather than systemic. Inhaled corticosteroids can increase fat deposits in the tissues surrounding the upper airway, particularly around the throat and tongue. They also alter the structure of the tongue muscles, weakening the dilator muscles that normally keep the airway open during sleep. Standard-particle-size inhalers were linked to a 56% increased risk of sleep apnea, while extra-fine particle formulations did not show a significant increase, suggesting the drug’s physical deposition in the throat matters.
The Two-Way Cycle
What makes this pairing particularly problematic is that sleep apnea also worsens asthma. The relationship creates a self-reinforcing cycle that can be difficult to break without addressing both conditions.
During apnea episodes, oxygen levels drop and the body mounts a stress response. This triggers a wave of inflammatory signals throughout the body, which compounds the inflammation already present in asthmatic airways. The repeated physical strain of trying to breathe against a closed airway also causes local tissue damage, swelling, and scarring in the throat, which feeds back into the asthma cycle.
Low oxygen levels during sleep also increase nerve activity that tightens the airways, triggering nighttime asthma attacks. Blood pools in the lungs due to the extreme pressure swings created by apnea episodes, which further irritates the airways and heightens their tendency to constrict. Over time, these changes shift the type of inflammation in the lungs toward a pattern that responds poorly to standard asthma treatments, including corticosteroids.
The clinical consequences are measurable. People with both conditions experience a 20% increase in hospitalization rates and a 25% increase in asthma flare-ups compared to those with asthma alone.
Telling Nighttime Asthma Apart From Sleep Apnea
Both conditions disrupt sleep and cause nighttime breathing problems, which makes them easy to confuse. Nocturnal asthma typically causes coughing, wheezing, and chest tightness that wake you up. Sleep apnea is more commonly associated with loud snoring, gasping or choking during sleep, and waking with a dry mouth or headache. Daytime sleepiness that seems out of proportion to your sleep hours is a hallmark of sleep apnea.
In practice, the overlap is significant enough that symptoms alone often can’t distinguish the two. Many people with both conditions assume their nighttime awakenings are entirely due to asthma and never get evaluated for sleep apnea. If your asthma seems difficult to control despite following your treatment plan, or if a partner notices pauses in your breathing at night, a sleep study can clarify whether sleep apnea is part of the picture. A formal sleep study remains the definitive way to diagnose sleep apnea, since symptom questionnaires miss many cases.
What Treating Sleep Apnea Does for Asthma
Because the two conditions amplify each other, treating sleep apnea often improves asthma control. Continuous positive airway pressure (CPAP) therapy, which uses a bedside machine to keep the airway open during sleep, addresses the mechanical stress, oxygen drops, and inflammatory surges that worsen asthma overnight. Reducing those triggers can lower the frequency of nighttime asthma attacks and decrease the overall inflammatory burden in the airways.
The clinical picture supports this integrated approach. The united airway concept, now widely accepted in pulmonology, holds that the nasal passages, throat, and lungs function as a single connected system. Inflammation in one segment affects the others. Treating nasal congestion with appropriate therapies can improve both asthma and sleep apnea. Similarly, getting sleep apnea under control removes a source of inflammation that keeps asthma unstable, potentially reducing the need for high-dose corticosteroids, which in turn may lower the medication-driven risk of worsening sleep apnea.
If you have asthma and recognize symptoms of sleep apnea in yourself, getting evaluated creates an opportunity to improve both conditions simultaneously rather than chasing one diagnosis while the other quietly makes it worse.